ArticleThe East African health research journal2025
Antimicrobial Activity of Zinc Oxide Nanoparticles and
Article in The East African health research journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The increasing trends in antimicrobial resistance (AMR) have continued to pose a global public health concern. This rapid emergence and spread of antimicrobial resistance have necessitated the exploration of innovative approaches to combat microbial infections. This study investigated the potential of enhancing antimicrobial properties through the synergistic effect of zinc oxide nanoparticles (ZnO NPs) and Methods: Zinc oxide nanoparticles (ZnO NPs), were synthesised using the sol-gel method and later synergised with extracts of Allium sativum. Formation of ZnO NPs was confirmed using X-ray diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR) and UV-visible spectrophotometry methods. Similarly, these methods were also used in formed Results: The average size of ZnO NPs in the present study is 40.96nm with a percentage crystallinity of 58.30%. The minimum inhibitory concentrations (MIC) of ZnO NPs ranged from 5 to 0.312 mg/ml. The antimicrobial assay of both ZnO NPs and crude Conclusion: Our findings confirm the promising use of zinc oxide nanoparticles (ZnO NPs) in treating pathogenic
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.